<p>➀ Redpoint Oncology and Fourier won the 2025 MassChallenge Technology in Space Prize, receiving $650,000+ for ISS-based research; </p><p>➁ Redpoint Oncology develops antibody-drug conjugates (ADCs) for microgravity-accelerated cancer therapy testing, while Fourier tests lightweight radiation-shielding CMC materials for satellite electronics; </p><p>➂ The award, funded by Boeing and CASIS, has supported over 30 projects with $20 million in 11 years.</p>
Related Articles
- Elon Musk says President Trump has asked SpaceX to bring astronauts stranded on ISS home ASAP9 months ago
- Applications closing for ISS’s Orbital Edge Accelerator programme5 months ago
- Redwire boosts PIL-BOX in-space drug development technology5 months ago
- Picture of the Day: ELVIS, the holographic microscope6 months ago
- Space Foundation report highlights growing U.S. space workforce6 months ago
- ISS astronauts witness Starship exploding and falling back to Earth7 months ago
- ISS National Lab report outlines scope of research in space9 months ago
- Boeing & Airbus: Deliveries & Profits9 months ago
- Debt, Drama, And Dreams: Why A Boeing Recovery Could Pay Off Handsomelyabout 1 year ago
- Why NASA’s Decision To Return Boeing’s Broken Starliner Uncrewed Was Spot-Onabout 1 year ago